Open Access. Powered by Scholars. Published by Universities.®
- Keyword
- File Type
Articles 1 - 2 of 2
Full-Text Articles in Entire DC Network
Botox Onabotulinumtoxina: Meta-Analysis Of The Severity Of Off-Label Botox Use In Children With Cerebral Palsy, Erica A. Morris
Botox Onabotulinumtoxina: Meta-Analysis Of The Severity Of Off-Label Botox Use In Children With Cerebral Palsy, Erica A. Morris
Student Scholar Showcase
Abstract
The brand name Botox was first assigned to a batch of botulinum toxin serotype A by Stanley Fahn, internationally avowed Doctor of Medicine and member of the Psychopharmacology Advisory Committee for the Food and Drug Administration (Erbguth, 2009; Fahn, 2016). Botulinum toxin is classified as one of the most potent toxic substances in the world. Efficacy for the therapeutic use of botulinum toxin is based upon the premise that botulinum toxin remains in the peripheral nervous system and is incapable of breaching the Blood-Brain Barrier (Tenenbaum, 2016). Since receiving initial approval in 1989 botulinum toxin serotype A now also …
Some Secrets Should Be Shared: Implementing An Evidence-Based Suicide Prevention Program, Meghan W. Diamon
Some Secrets Should Be Shared: Implementing An Evidence-Based Suicide Prevention Program, Meghan W. Diamon
National Youth Advocacy and Resilience Conference
Youth suicide is a preventable tragedy that can occur when children's mental health needs are unmet. Participants will discuss published research on risk factors for youth suicide, how to implement an evidence-based prevention program, and how to tackle common obstacles encountered. Participants will be prepared to mobilize school staff, parents, and community members to address the critical issues of depression awareness and suicide prevention.